Key result
Intramedullary nailing for skeletal metastatic disease was associated with a 7.1% overall rate of venous thromboembolism, with lung-cancer histology increasing this risk.
Why the study?
What is the risk of venous thromboembolism in patients undergoing intramedullary nailing for skeletal metastatic disease?
Cohort (n=287)
Yes
What is the risk of venous thromboembolism in patients undergoing intramedullary nailing for skeletal metastatic disease?
Patients undergoing intramedullary nailing for skeletal metastatic disease experience a high rate of VTE despite postoperative prophylaxis, suggesting current anticoagulation protocols may be inadequate.
Answers are grounded in this paper and cite their sources.
High VTE rates persist despite prophylaxis after metastatic nailing; leaves open optimal regimens for this high-risk population.
BACKGROUND: The risk of venous thromboembolism (VTE) in patients undergoing intramedullary nailing for skeletal metastatic disease is currently undefined. The purpose of our study was to determine the risk of thromboembolic events, to define the risk factors for VTE, and to define the rate of wound complications in this population. METHODS: A retrospective review of surgical databases at three National Cancer Institute (NCI)-designated cancer centers identified 287 patients with a total of 336 impending or pathologic long-bone fractures that were stabilized with intramedullary nailing between February 2001 and April 2013. Statistical analysis was performed utilizing multivariable logistic regression and Fisher exact tests. RESULTS: The overall rate of VTE was twenty-four (7.1%) of the 336; thirteen (3.9%) were pulmonary embolism (PE), and eleven (3.3%), deep venous thrombosis (DVT). In two patients, adequate anticoagulation data were not available. We found no significant relationship between the type of anticoagulant used and VTE. There was a significant positive correlation found between lung-cancer histology and the development of VTE (p < 0.001) or PE (p < 0.001). The absence of radiation therapy approached significance (p = 0.06) with respect to decreased overall VTE risk. Wound complications were documented for 11 (3.3%) of the operations. CONCLUSIONS: There is a high rate of VTE among those with skeletal metastatic disease who undergo intramedullary nailing, even while receiving postoperative thromboembolic prophylaxis. Current anticoagulation protocols may be inadequate. Wound-complication risk with anticoagulant use in this population is low and should not be a deterrent to adequate anticoagulant use for this population.
No takes yet. Share an insight, caveat, or question.
Shallop et al. (2015) conducted a cohort in Skeletal metastatic disease (n=287). Intramedullary nailing was evaluated on Venous thromboembolism (VTE). Intramedullary nailing for skeletal metastatic disease was associated with a 7.1% overall rate of venous thromboembolism, with lung-cancer histology increasing this risk.
Synapse has enriched 10 related papers. Consider them for comparative context: